(Q40708964)

23 September 2017

Intranasal vaccination with adjuvant-free S. aureus antigens effectively protects mice against experimental sepsis (English)

1 reference

Herbert Leonel DE Matos Guedes

23 September 2017

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Nataly Pescinalli Stegmiller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Estevão Carlos Barcelos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Janine Miranda Leal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Luciana Polaco Covre

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Dirlei Molinari Donatele

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Marco Cesar Cunegundes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Rodrigo Ribeiro Rodrigues

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Daniel Cláudio Oliviera Gomes

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

English

0 references

publication date

15 April 2016

1 reference

23 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

3493-3499

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

Treatment of hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Endocarditis caused by Staphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

A doxycycline-loaded polymer-lipid encapsulation matrix coating for the prevention of implant-related osteomyelitis due to doxycycline-resistant methicillin-resistant Staphylococcus aureus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Blockade of indoleamine 2,3-dioxygenase reduces mortality from peritonitis and sepsis in mice by regulating functions of CD11b+ peritoneal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Development of a vaccine against Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Immune response versus mucosal tolerance to mucosally administered antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Intranasal immunization with LACK-DNA promotes protective immunity in hamsters challenged with Leishmania chagasi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Intranasal vaccination with leishmanial antigens protects golden hamsters (Mesocricetus auratus) against Leishmania (Viannia) Braziliensis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Advances and challenges in mucosal adjuvant technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Toxicity evaluation of zinc aluminium levodopa nanocomposite via oral route in repeated dose study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Early inhibition of IL-1β expression by IFN-γ is mediated by impaired binding of NF-κB to the IL-1β promoter but is independent of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Efficacy of vaccination against staphylococcal mastitis: a review and new data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

Priming by microbial antigens from the intestinal flora determines the ability of CD4+ T cells to rapidly secrete IL-4 in BALB/c mice infected with Leishmania major.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.04.018

10.1016/J.VACCINE.2016.04.018

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27091687%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference